These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 19532109)

  • 21. Physical exercise and Parkinson's disease: influence on symptoms, disease course and prevention.
    Grazina R; Massano J
    Rev Neurosci; 2013; 24(2):139-52. PubMed ID: 23492553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine-, Neurotrophin-, and Motor Rehabilitation-Induced Plasticity in Parkinson's Disease.
    Policastro G; Brunelli M; Tinazzi M; Chiamulera C; Emerich DF; Paolone G
    Neural Plast; 2020; 2020():8814028. PubMed ID: 33293946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerobic exercise intervention improves aerobic capacity and movement initiation in Parkinson's disease patients.
    Bergen JL; Toole T; Elliott RG; Wallace B; Robinson K; Maitland CG
    NeuroRehabilitation; 2002; 17(2):161-8. PubMed ID: 12082243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determining the optimal challenge point for motor skill learning in adults with moderately severe Parkinson's disease.
    Onla-or S; Winstein CJ
    Neurorehabil Neural Repair; 2008; 22(4):385-95. PubMed ID: 18326891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease.
    Kalda A; Yu L; Oztas E; Chen JF
    J Neurol Sci; 2006 Oct; 248(1-2):9-15. PubMed ID: 16806272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of animal models of Parkinson's disease for neuroprotective strategies.
    Emborg ME
    J Neurosci Methods; 2004 Oct; 139(2):121-43. PubMed ID: 15488225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety and feasibility of high-force eccentric resistance exercise in persons with Parkinson's disease.
    Dibble LE; Hale T; Marcus RL; Gerber JP; Lastayo PC
    Arch Phys Med Rehabil; 2006 Sep; 87(9):1280-2. PubMed ID: 16935068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rehabilitative approaches to Parkinson's disease.
    Montgomery EB
    Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S43-7. PubMed ID: 15109586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging the impact of genes on Parkinson's disease.
    van der Vegt JP; van Nuenen BF; Bloem BR; Klein C; Siebner HR
    Neuroscience; 2009 Nov; 164(1):191-204. PubMed ID: 19409223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of a self-supervised home exercise program with a physiotherapist-supervised exercise program on the motor symptoms of Parkinson's disease.
    Lun V; Pullan N; Labelle N; Adams C; Suchowersky O
    Mov Disord; 2005 Aug; 20(8):971-5. PubMed ID: 15838853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?
    Clarke CE
    Mov Disord; 2008 Apr; 23(6):784-9. PubMed ID: 18175348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of computerized dynamic posturography therapy to standard balance physical therapy in individuals with Parkinson's disease: a pilot study.
    Qutubuddin AA; Cifu DX; Armistead-Jehle P; Carne W; McGuirk TE; Baron MS
    NeuroRehabilitation; 2007; 22(4):261-5. PubMed ID: 17971615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The validity of the GaitRite and the Functional Ambulation Performance scoring system in the analysis of Parkinson gait.
    Nelson AJ; Zwick D; Brody S; Doran C; Pulver L; Rooz G; Sadownick M; Nelson R; Rothman J
    NeuroRehabilitation; 2002; 17(3):255-62. PubMed ID: 12237507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between environmental and genetic factors in the pathophysiology of Parkinson's disease.
    Tsang F; Soong TW
    IUBMB Life; 2003 Jun; 55(6):323-7. PubMed ID: 12938734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
    Marek K; Jennings D; Tamagnan G; Seibyl J
    Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the genetics of Parkinson's disease.
    Rosner S; Giladi N; Orr-Urtreger A
    Acta Pharmacol Sin; 2008 Jan; 29(1):21-34. PubMed ID: 18158863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of incremental speed-dependent treadmill training on postural instability and fear of falling in Parkinson's disease.
    Cakit BD; Saracoglu M; Genc H; Erdem HR; Inan L
    Clin Rehabil; 2007 Aug; 21(8):698-705. PubMed ID: 17846069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasticity of the nigropallidal pathway in Parkinson's disease.
    Whone AL; Moore RY; Piccini PP; Brooks DJ
    Ann Neurol; 2003 Feb; 53(2):206-13. PubMed ID: 12557287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Norepinephrine and cardiovascular responses to maximal exercise in Parkinson's disease on and off medication.
    DiFrancisco-Donoghue J; Elokda A; Lamberg EM; Bono N; Werner WG
    Mov Disord; 2009 Sep; 24(12):1773-8. PubMed ID: 19562762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.